Literature DB >> 25136008

Identification and characterization of linezolid-resistant cfr-positive Staphylococcus aureus USA300 isolates from a New York City medical center.

Jeffrey B Locke1, Douglas E Zuill2, Caitlyn R Scharn3, Jennifer Deane4, Daniel F Sahm4, Richard V Goering3, Stephen G Jenkins5, Karen J Shaw2.   

Abstract

The cfr gene was identified in three linezolid-resistant USA300 methicillin-resistant Staphylococcus aureus (MRSA) isolates collected over a 3-day period at a New York City medical center in 2011 as part of a routine surveillance program. Each isolate possessed a plasmid containing a pSCFS3-like cfr gene environment. Transformation of the cfr-bearing plasmids into the S. aureus ATCC 29213 background recapitulated the expected Cfr antibiogram, including resistance to linezolid, tiamulin, clindamycin, and florfenicol and susceptibility to tedizolid.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25136008      PMCID: PMC4249436          DOI: 10.1128/AAC.03380-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Single-primer PCR procedure for rapid identification of transposon insertion sites.

Authors:  A V Karlyshev; M J Pallen; B W Wren
Journal:  Biotechniques       Date:  2000-06       Impact factor: 1.993

2.  Transcriptional and translational control of the mlr operon, which confers resistance to seven classes of protein synthesis inhibitors.

Authors:  Lisa K Smith; Alexander S Mankin
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

3.  The Cfr rRNA methyltransferase confers resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics.

Authors:  Katherine S Long; Jacob Poehlsgaard; Corinna Kehrenberg; Stefan Schwarz; Birte Vester
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

4.  Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates.

Authors:  Corinna Kehrenberg; Stefan Schwarz
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

5.  Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United States.

Authors:  Rodrigo E Mendes; Robert K Flamm; Patricia A Hogan; James E Ross; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

6.  Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid.

Authors:  Seok-Ming Toh; Liqun Xiong; Cesar A Arias; Maria V Villegas; Karen Lolans; John Quinn; Alexander S Mankin
Journal:  Mol Microbiol       Date:  2007-06       Impact factor: 3.501

7.  In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.

Authors:  K J Shaw; S Poppe; R Schaadt; V Brown-Driver; J Finn; C M Pillar; D Shinabarger; G Zurenko
Journal:  Antimicrob Agents Chemother       Date:  2008-10-06       Impact factor: 5.191

8.  Linezolid surveillance program results for 2008 (LEADER Program for 2008).

Authors:  David J Farrell; Rodrigo E Mendes; James E Ross; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2009-12       Impact factor: 2.803

9.  First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.

Authors:  Rodrigo E Mendes; Lalitagauri M Deshpande; Mariana Castanheira; Joseph DiPersio; Michael A Saubolle; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

10.  In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent.

Authors:  Ronda Schaadt; Debora Sweeney; Dean Shinabarger; Gary Zurenko
Journal:  Antimicrob Agents Chemother       Date:  2009-06-15       Impact factor: 5.191

View more
  7 in total

Review 1.  Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.

Authors:  George G Zhanel; Riley Love; Heather Adam; Alyssa Golden; Sheryl Zelenitsky; Frank Schweizer; Bala Gorityala; Philippe R S Lagacé-Wiens; Ethan Rubinstein; Andrew Walkty; Alfred S Gin; Matthew Gilmour; Daryl J Hoban; Joseph P Lynch; James A Karlowsky
Journal:  Drugs       Date:  2015-02       Impact factor: 9.546

2.  In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model.

Authors:  Alexander J Lepak; Ajit Parhi; Michaela Madison; Karen Marchillo; Jamie VanHecker; David R Andes
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

3.  In vitro activity of tedizolid against Staphylococcus aureus and Streptococcus pneumoniae collected in 2013 and 2014 from sites in Latin American countries, Australia, New Zealand, and China.

Authors:  D J Biedenbach; S K Bouchillon; B Johnson; J Alder; D F Sahm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-27       Impact factor: 3.267

Review 4.  RNA Degradation in Staphylococcus aureus: Diversity of Ribonucleases and Their Impact.

Authors:  Rémy A Bonnin; Philippe Bouloc
Journal:  Int J Genomics       Date:  2015-04-21       Impact factor: 2.326

5.  Using genomics to understand meticillin- and vancomycin-resistant Staphylococcus aureus infections.

Authors:  Stefano G Giulieri; Steven Y C Tong; Deborah A Williamson
Journal:  Microb Genom       Date:  2020-01

6.  Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria.

Authors:  Stefan Schwarz; Wanjiang Zhang; Xiang-Dang Du; Henrike Krüger; Andrea T Feßler; Shizhen Ma; Yao Zhu; Congming Wu; Jianzhong Shen; Yang Wang
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

7.  First Report of cfr-Carrying Plasmids in the Pandemic Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Staphylococcal Cassette Chromosome mec Type IV Clone.

Authors:  Anna C Shore; Alexandros Lazaris; Peter M Kinnevey; Orla M Brennan; Gráinne I Brennan; Brian O'Connell; Andrea T Feßler; Stefan Schwarz; David C Coleman
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.